Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics

Recently, cyclin-dependent kinase (CDK) 4/6 inhibitors have been widely used to treat advanced hormone receptor-positive breast cancer. Despite promising clinical outcomes, almost all patients eventually acquire resistance to CDK4/6 inhibitors. Here, we screened genes associated with palbociclib res...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Kamal, Lee, Eunbyeol, Park, Nahee, Hur, Jin, Cho, Young Bin, Katuwal, Nar Bahadur, Kim, Seung Ki, Lee, Seung Ah, Kim, Isaac, An, Hee Jung, Hwang, Sohyun, Moon, Yong Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912104/
https://www.ncbi.nlm.nih.gov/pubmed/33504001
http://dx.doi.org/10.3390/genes12020159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912104/
https://www.ncbi.nlm.nih.gov/pubmed/33504001
http://dx.doi.org/10.3390/genes12020159

Ejemplares similares